|
|
|
|
|
Chemotherapy
induced nausea and vomiting (CINV) |
Phase
II/III |
NDA |
|
Alzheimer's
disease and cognitive disorders |
Phase
I/II |
Completion
of Phase II clinical trial |
|
HIV
Latency |
Phase
I/II |
IND |
|
Hormone
refractory prostate cancer (HRPCA) |
Nonclinical |
IND |
|
Breast
and ovarian cancers |
Nonclinical |
IND |
|
Colorectal
cancer |
Nonclinical |
IND |
|
Kaposi's
sarcoma, skin cancers |
Nonclinical |
IND |
|
Chemoprevention |
Preclinical |
Nanoformulation |
|
Pancreatic
cancer |
Research |
In
vivo testing |
|
Cancer
pain, AIDS cachexia |
Research |
Nanoformulation |
|
Mild
to moderate depression |
Research |
Formulation
and testing |
